
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 1.760 | 1.760 | 0.000 |
Shares | 98.240 | 98.240 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 26.774 | 22.113 |
Price to Book | 4.104 | 3.714 |
Price to Sales | 4.118 | 2.893 |
Price to Cash Flow | 18.768 | 16.109 |
Dividend Yield | 1.510 | 2.123 |
5 Years Earnings Growth | 7.577 | 9.181 |
Name | Net % | Category Average |
---|---|---|
Healthcare | 25.420 | 14.663 |
Technology | 22.250 | 17.319 |
Industrials | 20.270 | 25.863 |
Basic Materials | 10.960 | 6.915 |
Consumer Cyclical | 9.600 | 11.317 |
Consumer Defensive | 8.960 | 7.870 |
Financial Services | 2.540 | 11.294 |
Number of long holdings: 38
Number of short holdings: 0
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
ASML Holding | NL0010273215 | 5.46 | 706.10 | +2.74% | |
Schneider Electric | FR0000121972 | 5.04 | 225.85 | +0.98% | |
Air Liquide | FR0000120073 | 4.98 | 173.80 | -0.61% | |
Alcon | CH0432492467 | 4.46 | 68.94 | -1.12% | |
EssilorLuxottica | FR0000121667 | 4.26 | 242.20 | -0.66% | |
Relx | GB00B2B0DG97 | 4.17 | 3,983.00 | -0.72% | |
Novo Nordisk B | DK0062498333 | 3.77 | 433.1 | -2.28% | |
Dassault Systemes | FR0014003TT8 | 3.68 | 31.82 | +0.89% | |
Novozymes AS | DK0060336014 | 3.54 | 448.7 | -0.97% | |
Amadeus | ES0109067019 | 3.45 | 70.840 | -1.25% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Europe EUR Acc | 4.34B | -2.61 | 7.35 | 7.55 | ||
Europe EUR Dis | 4.34B | -2.62 | 7.34 | 7.54 | ||
IE00BYYLQ421 | 961.05M | 17.12 | 5.17 | 11.09 | ||
IE00BJ625P22 | 961.05M | 17.14 | 5.22 | 11.12 | ||
IE00B6X2JP23 | 956.87M | -7.08 | 12.14 | 11.30 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review